These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 11966338)
1. Antithrombotic treatment and the incidence of angina pectoris. Knottenbelt C; Brennan PJ; Meade TW; Arch Intern Med; 2002 Apr; 162(8):881-6. PubMed ID: 11966338 [TBL] [Abstract][Full Text] [Related]
2. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092 [TBL] [Abstract][Full Text] [Related]
3. Coronary artery flow ten weeks after myocardial infarction or unstable angina: effects of combined warfarin and aspirin therapy. Williams MJ; Stewart RA Int J Cardiol; 1999 Apr; 69(1):19-25. PubMed ID: 10362368 [TBL] [Abstract][Full Text] [Related]
4. Thrombosis prevention trial: compliance with warfarin treatment and investigation of a retained effect. Rudnicka AR; Ashby D; Brennan P; Meade T Arch Intern Med; 2003 Jun; 163(12):1454-60. PubMed ID: 12824095 [TBL] [Abstract][Full Text] [Related]
6. Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Manson JE; Grobbee DE; Stampfer MJ; Taylor JO; Goldhaber SZ; Gaziano JM; Ridker PM; Buring JE; Hennekens CH Am J Med; 1990 Dec; 89(6):772-6. PubMed ID: 2252045 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group). Cohen M; Adams PC; Hawkins L; Bach M; Fuster V Am J Cardiol; 1990 Dec; 66(19):1287-92. PubMed ID: 2244556 [TBL] [Abstract][Full Text] [Related]
8. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit. Rothberg MB; Celestin C; Fiore LD; Lawler E; Cook JR Ann Intern Med; 2005 Aug; 143(4):241-50. PubMed ID: 16103468 [TBL] [Abstract][Full Text] [Related]
9. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease. Thompson PL; Verheugt FW Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549 [TBL] [Abstract][Full Text] [Related]
10. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Cohen M; Adams PC; Parry G; Xiong J; Chamberlain D; Wieczorek I; Fox KA; Chesebro JH; Strain J; Keller C Circulation; 1994 Jan; 89(1):81-8. PubMed ID: 8281698 [TBL] [Abstract][Full Text] [Related]
11. How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database. Rietbrock S; Plumb JM; Gallagher AM; van Staa TP Thromb Haemost; 2009 Mar; 101(3):527-34. PubMed ID: 19277415 [TBL] [Abstract][Full Text] [Related]
12. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085 [TBL] [Abstract][Full Text] [Related]
13. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results. Anand SS; Yusuf S; Pogue J; Weitz JI; Flather M Circulation; 1998 Sep; 98(11):1064-70. PubMed ID: 9736592 [TBL] [Abstract][Full Text] [Related]